- (1) For representative examples of N-heterocycle synthesis from anthranilic acid derivatives see: a) Vicente, R. Org. Biomol. Chem. 2011, 9, 6469-6480; b) Prajapati, S. M.; Patel, K. D.; Vekariya, R. H.; Panchal, S. N.; Patel, H. D. RSC Adv. 2014, 4, 24463-24476; c) Connolly, D. J.; Cusack, D.; T. P.; Guiry, P. J. Tetrahedron 2005, 61, 10153-10202.
- (2) For representative reviews on C-H activation see: a) Chen, X.; Engle, K. M.; Wang, D.-H.; Yu, J.-Q. Angew. Chem. Int. Ed. 2009, 48, 5094-5115; b) Sarkar, S. D.; Liu, W.; Kozhushkov, I.; Ackermann, L. Adv. Synth. Catal. 2014, 356, 1461-1429; c) Song, G.; Wang, F.; Li, X.; Chem. Soc. Rev. 2012, 41, 3651- 3678; d) Daugulis, O.; Roane, J.; Tran, L. D. Acc. Chem. Res. 2015, 48, 1053-1064; e) Lyons, T. W.; Sanford, M. Chem. Rev. 2010, 110, 1147-1169; f) Colby, D. A.; Tsai, A. S.; Bergman, R. G.; Ellman, J. A. Acc. Chem. Res. 2012, 45, 814-825. For C-H activation approaches to anthranilic acid derivative synthesis see: a) Ng, K.-H.; Chan, A. S. C.; Yu, W.-Y. J. Am. Chem. Soc. 2010, 132, 12862-12864; b) Xiao, B.; Gong, T.-J.; Xu, J.; Liu, Z.-J.; Liu, L. J. Am. Chem. Soc. 2011, 133, 1466- 1474; c) Ryu, J.; Shin, K.; Park, S. H.; Kim, J. Y.; Chang, S. Angew. Chem. Int. Ed. 2012, 51, 9904-9908; d) Grohmann, C.; Wang, H.; Glorius, F. Org. Lett. 2013, 15, 3014-3017; e) Kim, J.; Chang, S. Angew. Chem. Int. Ed. 2014, 53, 2203-2207; f) Giri, R; Lam, J. K.; Yu, J.-Q. J. Am. Chem. Soc. 2010, 132, 686-693.
- (4) Maiden, T. M. M., Swanson, S.; Procopiou, P. A.; Harrity, J. P. A. Chem.-Eur. J. 2015, 21, 14342-14346.
- (5) Mei, R.; Loup, J.; Ackermann, L. ACS Catal 2016, 6, 793-797.
- (6) Qin, Q.; Yu, S.; Org. Lett. 2014, 16, 3504-3507.
- (7) Shang, M.; Zeng, S.-H.; Sun, S.-Z.; Dai, H.-X.; Yu, J.-Q. Org. Lett., 2013, 15, 5286-5289.
- (8) Matsubara, T.; Asako, S.; Ilies, L.; Nakamura, E. J. Am. Chem. Soc. 2014, 136, 646-649.
- (9) For reported C-H amidation upon pyridines see: a) Shang, M.; Sun, S.-Z.; Dai, H.-X.; Yu, J.-Q. J. Am. Chem. Soc. 2014, 136, 3354-3357; b) Tran, L. D.; Roane, J.; Daugulis, O. Angew. Chem. Int. Ed. 2013, 52, 6043-6046; c) Roane, J.; Daugulis, O. J. Am. Chem. Soc. 2016, 138, 4601-46-47.
- (10) For further details see Supporting Information.
- (11) Lafaye, K.; Nicolas, L.; Guérinot, A.; Reymond, S.; Cossy, J. Org. Lett. 2014, 16, 4972-4975.
- (12) Subjecting these substrates to reaction conditions in CD3OD failed to return deuterated substrate, see Supporting Information for details. For the use of related compounds as ligands for transition metal catalysis see: Nishiyama, H.; Yamaguchi, S.; Park, S-B.; Itoh, K. Tetrahedron: Asymmetry, 1993, 4, 143-150.
- (13) Chang, L.; Lee, S.-Y.; Leonczak, P.; Rozenski, J.; De Jonghe, S.; Hanck, T.; Muller, C. E.; Herdwijn, P. J. Med. Chem. 2014, 57, 10080-10100.
- (14) a) Chai, Y.; Paul, Y.; Rettig, M.; Wilson, W. D.; Boykin, D. W. J. Org. Chem. 2014, 79, 852-866; b) Fürstner, A.; Leitner, A.; Méndez, M.; Krause, H.; J. Am. Chem. Soc. 2002, 124, 13856- 13863; c) Petersen, J. G.; Sørensen, T.; Damgaard, M.; Nielsen, B.; Jensen, A. A.; Balle, T.; Bergmann, R.; Frølund, B. Eur. J. Med. Chem. 2014, 84, 404-416.
- (15) Sadler, S. A.; Tajuddin, H.; Mkhalid, I. A. I.; Batsanov, A. S.; Albesa-Jove, D.; Cheung, M. S.; Maxwell, A. C.; Shukla, L.; Roberts, B.; Blakemore, D. C.; Lin, Z.; Marder, T. B.; Steel, P. G.; Org. Biomol. Chem. 2014, 12, 7318-7327.
- (16) Crawford, T. D.; Ndubaku, C. O.; Chen, H.; Boggs, J. W.; Bravo, B. J.; DeLaTorre, K.; Giannetti, A. M.; Gould, S. E.; Harris, S. F.; Magnuson, S. R.; McNamara, E.; Murray, L. J.; Nonomiya, J.; Sambrone, A.; Schmidt, S.; Smyczek, T.; Stanley, M.; Vitorino, P.; Wang, L.; West, K.; Wu, P.; Ye, W. J. Med. Chem. 2014, 57, 3484-3493.